Norketotifen

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameNorketotifen
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H1 receptor antagonists
TargetsHistamine H1 receptor
Therapy Area/IndicationsConjunctivitis, AllergicRhinitis, AllergicInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEmergo Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesEmergo Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsInfluenza, Human
Inactive IndicationsConjunctivitis, AllergicRhinitis, Allergic

Other Information

ATC CodeN/A
Related LinksN/A